Euronext-listed UCB, a Belgium-based global biopharmaceutical company, has acquired Neurona Therapeutics, a US-based clinical-stage biotherapeutics company developing regenerative cell therapies, for a total transaction valued of up to US$1.15bn consisting…
Belgium: UCB completes acquisition of Neurona Therapeutics
…
…






![France: News reports point to Warburg Pincus nearing deal to acquire stake in Sebia [UPDATE]](https://www.investorsinhealthcare.com/wp-content/uploads/2025/10/sebia-logo-100x70.jpg)